Conversations with OpenAI’s Sam Altman; Paymate to Resubmit IPO Papers

Date:

Large companies operating in the artificial intelligence (AI) space should be regulated but this should not affect startups, according to Sam Altman, founder and CEO of OpenAI that developed ChatGPT. He called for no regulation on smaller companies and stated that newer and better jobs should emerge, despite the potential for job losses. Altman added that AI is under-hyped in the long term, and that investors can’t calculate the worth of companies building AI products in the short term. In other news, Ajay Adiseshan, founder of Paymate, reveals the fintech firm is tapping international markets, including Gulf countries and South East Asia, ahead of filing fresh IPO papers. Meanwhile, Zomato is building an AI team to integrate AI into various customer-facing features, while Ola Electric is reportedly in talks with NR Narayana Murthy’s investment firm, Catamaran, to help raise $300m in a current funding round, following competitor Ola Cabs’ IPO.  

See also  Google Develops AI Writing and Editing Feature for Chromebooks, Plans Android Device Linking

Frequently Asked Questions (FAQs) Related to the Above News

Please note that the FAQs provided on this page are based on the news article published. While we strive to provide accurate and up-to-date information, it is always recommended to consult relevant authorities or professionals before making any decisions or taking action based on the FAQs or the news article.

Share post:

Subscribe

Popular

More like this
Related

Obama’s Techno-Optimism Shifts as Democrats Navigate Changing Tech Landscape

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tech Evolution: From Obama’s Optimism to Harris’s Vision

Explore the evolution of tech policy from Obama's optimism to Harris's vision at the Democratic National Convention. What's next for Democrats in tech?

Tonix Pharmaceuticals TNXP Shares Fall 14.61% After Q2 Earnings Report

Tonix Pharmaceuticals TNXP shares decline 14.61% post-Q2 earnings report. Evaluate investment strategy based on company updates and market dynamics.

The Future of Good Jobs: Why College Degrees are Essential through 2031

Discover the future of good jobs through 2031 and why college degrees are essential. Learn more about job projections and AI's influence.